FENOFIBRATE (MICRONIZED) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fenofibrate (micronized), and what generic alternatives are available?
Fenofibrate (micronized) is a drug marketed by Ajanta Pharma Ltd, Alembic, Ani Pharms, Apotex, Aurobindo Pharma Ltd, Dr Reddys Labs Sa, Glenmark Pharms Ltd, Impax Labs, Invagen Pharms, Mylan Pharms Inc, Novast Labs, Reyoung, Rhodes Pharms, Rising, Torrent, and Youngtech Pharms Inc. and is included in sixteen NDAs.
The generic ingredient in FENOFIBRATE (MICRONIZED) is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fenofibrate (micronized)
A generic version of FENOFIBRATE (MICRONIZED) was approved as fenofibrate by RHODES PHARMS on May 13th, 2005.
Summary for FENOFIBRATE (MICRONIZED)
US Patents: | 0 |
Applicants: | 16 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 16 |
Raw Ingredient (Bulk) Api Vendors: | 138 |
Clinical Trials: | 7 |
Patent Applications: | 3,839 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FENOFIBRATE (MICRONIZED) at DailyMed |
Recent Clinical Trials for FENOFIBRATE (MICRONIZED)
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Beijing Chao Yang Hospital | Phase 4 |
Hanlim Pharm. Co., Ltd. | Phase 1 |
University of Ioannina | Phase 4 |